These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2139281)

  • 1. Hepatitis B: global importance and need for control.
    Maynard JE
    Vaccine; 1990 Mar; 8 Suppl():S18-20; discussion S21-3. PubMed ID: 2139281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization.
    Maynard JE; Kane MA; Hadler SC
    Rev Infect Dis; 1989; 11 Suppl 3():S574-8. PubMed ID: 2527402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
    Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
    Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global programme for control of hepatitis B infection.
    Kane M
    Vaccine; 1995; 13 Suppl 1():S47-9. PubMed ID: 7571830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World-wide control of hepatitis B.
    Maynard JE
    Int J Epidemiol; 1984 Dec; 13(4):406-7. PubMed ID: 6240473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation.
    Posuwan N; Wanlapakorn N; Sa-Nguanmoo P; Wasitthankasem R; Vichaiwattana P; Klinfueng S; Vuthitanachot V; Sae-Lao S; Foonoi M; Fakthongyoo A; Makaroon J; Srisingh K; Asawarachun D; Owatanapanich S; Wutthiratkowit N; Tohtubtiang K; Yoocharoen P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2016; 11(3):e0150499. PubMed ID: 26938736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.
    Luo Z; Li L; Ruan B
    Int J Infect Dis; 2012 Feb; 16(2):e82-8. PubMed ID: 22178658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus and the control of hepatocellular carcinoma.
    Blumberg BS
    IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatitis B virus infection on women and children.
    Shapiro CN; Margolis HS
    Infect Dis Clin North Am; 1992 Mar; 6(1):75-96. PubMed ID: 1533649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Vaccine in national immunization schedule: a preventive step in India.
    Verma R; Khanna P; Prinja S; Rajput M; Chawla S; Bairwa M
    Hum Vaccin; 2011 Dec; 7(12):1387-8. PubMed ID: 22134433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives.
    McMahon BJ; Rhoades ER; Heyward WL; Tower E; Ritter D; Lanier AP; Wainwright RB; Helminiak C
    Lancet; 1987 Nov; 2(8568):1134-6. PubMed ID: 2444845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa.
    Amponsah-Dacosta E; Lebelo RL; Rakgole JN; Burnett RJ; Selabe SG; Mphahlele MJ
    J Med Virol; 2014 Jun; 86(6):918-24. PubMed ID: 24615635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular epidemiological study of the hepatitis B virus in Thailand after 22 years of universal immunization.
    Yimnoi P; Posuwan N; Wanlapakorn N; Tangkijvanich P; Theamboonlers A; Vongpunsawad S; Poovorawan Y
    J Med Virol; 2016 Apr; 88(4):664-73. PubMed ID: 26331587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa.
    Edmunds W; Dejene A; Mekonnen Y; Haile M; Alemnu W; Nokes D
    Health Policy Plan; 2000 Dec; 15(4):408-16. PubMed ID: 11124244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
    Zhao S; Xu Z; Lu Y
    Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection.
    Stevens CE; Toy PT; Taylor PE; Lee T; Yip HY
    Pediatrics; 1992 Jul; 90(1 Pt 2):170-3. PubMed ID: 1534885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.